Page last updated: 2024-09-05

sorafenib and chitosan

sorafenib has been researched along with chitosan in 10 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(chitosan)
Trials
(chitosan)
Recent Studies (post-2010) (chitosan)
6,5207305,25127,64823221,257

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (70.00)24.3611
2020's3 (30.00)2.80

Authors

AuthorsStudies
Bao, J; Dai, Z; Lan, Y; Tu, W; Wei, T; Zhao, B1
Arora, J; Boonkaew, B; Callaghan, C; Chava, S; Dash, S; He, J; John, VT; Lee, BR; Liu, J; Maddox, MM; Mandava, SH1
Liang, Y; Su, Z; Yao, Y; Zhang, N1
Fan, L; Jiang, K; Li, T; Shao, J; Zhao, R; Zheng, G1
Han, HK; Kim, HY; Lee, SH; Song, JG; Zhao, M1
Jahanian, A; Raghami, F; Rostami, M; Varshosaz, J1
Hou, T; Wang, T; Yin, X; Zhang, J; Zhang, N1
Chen, A; Cheng, CH; Chou, CM; Chu, CY; Lee, YA; Liu, CY; Liu, EH; Mi, FL; Wang, CY1
Awasthi, R; Dahiya, M; Dua, K; Dureja, H; Sharma, S; Yadav, JP1
Albalawi, F; Fakurazi, S; Hussein, MZ; Masarudin, MJ1

Other Studies

10 other study(ies) available for sorafenib and chitosan

ArticleYear
Electrochemical monitoring of an important biomarker and target protein: VEGFR2 in cell lysates.
    Scientific reports, 2014, Feb-05, Volume: 4

    Topics: Animals; Biosensing Techniques; Cell Line; Chitosan; Electrochemical Techniques; Endothelial Cells; Graphite; Immunoassay; Macaca mulatta; Niacinamide; Oxidation-Reduction; Phenothiazines; Phenylurea Compounds; Piperidines; Protein Kinase Inhibitors; Quinazolines; Retina; Sorafenib; Vascular Endothelial Growth Factor Receptor-2

2014
Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
    Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:3

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Kidney Neoplasms; Kinetics; Lactic Acid; Liposomes; Nanoparticles; Nanotechnology; Niacinamide; Phenylurea Compounds; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Sorafenib; Technology, Pharmaceutical

2015
pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cations; Cell Proliferation; Chitosan; Drug Delivery Systems; Female; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liposomes; Mice; Niacinamide; Phenylurea Compounds; RNA, Small Interfering; Sorafenib

2015
Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
    Biomaterials, 2017, Volume: 143

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Delayed-Action Preparations; Disaccharides; Drug Synergism; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Lung Neoplasms; Male; Mice; Nanoparticles; Niacinamide; Phenylurea Compounds; Porosity; Rats; Silicon Dioxide; Sorafenib; Triterpenes; Ursolic Acid

2017
Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome.
    International journal of pharmaceutics, 2018, Jun-10, Volume: 544, Issue:1

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Caco-2 Cells; Cell Survival; Chitosan; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Liposomes; Male; Niacinamide; Phenylurea Compounds; Polymethacrylic Acids; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Sorafenib

2018
PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2.
    Journal of liposome research, 2019, Volume: 29, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Membrane Permeability; Cell Survival; Chitosan; Delayed-Action Preparations; Drug Compounding; Drug Liberation; Emulsions; Hep G2 Cells; Humans; Liver Neoplasms; Nanocapsules; Octreotide; Polyethylene Glycols; Sorafenib; Surface Properties

2019
Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy.
    Nanoscale, 2019, Aug-07, Volume: 11, Issue:29

    Topics: Animals; Benzamides; Carcinoma, Hepatocellular; Cell Survival; Chitosan; Drug Carriers; Humans; Immunotherapy; Liver Neoplasms; Macrophages; Mannose; Mice; Microscopy, Confocal; Nanoparticles; Protein Kinase Inhibitors; RAW 264.7 Cells; Sorafenib; Tissue Distribution

2019
A low-molecular-weight chitosan fluorometric-based assay for evaluating antiangiogenic drugs.
    International journal of biological macromolecules, 2023, Jan-01, Volume: 224

    Topics: Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Chitosan; Endothelial Cells; Green Fluorescent Proteins; Sorafenib; Zebrafish

2023
Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization.
    International journal of biological macromolecules, 2023, Jul-01, Volume: 242, Issue:Pt 2

    Topics: Chitosan; Drug Carriers; Ferrosoferric Oxide; Humans; Magnetite Nanoparticles; Microscopy, Atomic Force; Nanoparticles; Particle Size; Sorafenib

2023
Fabrication and characterization of nanodelivery platform based on chitosan to improve the anticancer outcome of sorafenib in hepatocellular carcinoma.
    Scientific reports, 2023, 07-27, Volume: 13, Issue:1

    Topics: Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Humans; Liver Neoplasms; Nanoparticles; Sorafenib

2023